Exponent (EXPO)
(Delayed Data from NSDQ)
$95.39 USD
+1.01 (1.07%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $95.30 -0.09 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$95.39 USD
+1.01 (1.07%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $95.30 -0.09 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Zacks News
5 Consulting Stocks That are Resilient to Coronavirus Mayhem
by Shuvra Shankar Dey
One of the earliest pioneers of remote working, the consulting services industry has been aiding industry players sail through the current turbulence.
Analysts Estimate Exponent (EXPO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 11.36% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Business Services Apr 30 Earnings Roster: FCN, NLSN & More
by Zacks Equity Research
Here's a sneak peek into how five business service stocks are placed prior to their earnings releases on Apr 30
Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Exponent (EXPO) Outpaced Other Business Services Stocks This Year?
by Zacks Equity Research
Is (EXPO) Outperforming Other Business Services Stocks This Year?
Exponent (EXPO) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 9.09% and 6.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking for a Growth Stock? 3 Reasons Why Exponent (EXPO) is a Solid Choice
by Zacks Equity Research
Exponent (EXPO) possesses solid growth attributes, which could help it handily outperform the market.
Exponent Enters Oversold Territory
by Zacks Equity Research
Exponent has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Exponent (EXPO) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Exponent (EXPO) possesses solid growth attributes, which could help it handily outperform the market.
Exponent (EXPO) Tops Q3 Earnings Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 9.09% and -0.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Exponent (EXPO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Buy Stocks for October 10th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
The Zacks Analyst Blog Highlights: FTI, Exponent, Deluxe, CBIZ and Knoll
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FTI, Exponent, Deluxe, CBIZ and Knoll
Mixed Jobs Data for August Raise Rate Cut Hope: 5 Top Picks
by Nalak Das
Weak job growth, tepid manufacturing data, lower business spending and muted inflation are near-term concerns, which will likely compel the Fed to opt for a second rate cut in this month after July.
Exponent (EXPO) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Exponent (EXPO) possesses solid growth attributes, which could help it handily outperform the market.
Zacks.com featured highlights include: SSR Mining, Pretium Resources, Griffon, Exponent and MasTec
by Zacks Equity Research
Zacks.com featured highlights include: SSR Mining, Pretium Resources, Griffon, Exponent and MasTec
5 Stocks With Recent Price Strength Despite Market Volatility
by Nalak Das
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Consulting Services' Outlook Bright on Strong Economic Growth
by Shuvra Shankar Dey
Globalization, consolidation and digitization continue to support growth of this multi-billion-dollar industry.
Will Exponent Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Exponent.
Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 18.18% and 6.39%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Exponent (EXPO) Q2 Earnings Expected to Decline
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Consulting Services Stocks Worth Adding to Your Portfolio
by Shuvra Shankar Dey
The consulting services industry is doing well on the back of the strong U.S. economy.
3 Reasons Why Growth Investors Shouldn't Overlook Exponent (EXPO)
by Zacks Equity Research
Exponent (EXPO) could produce exceptional returns because of its solid growth attributes.